missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ LV-MAX™ Lentiviral Production System

Codice prodotto. 15829081 Sfoglia Tutto Gibco Prodotti
Cambia vista
Click to view available options
Quantità:
1 Kit
Dimensione della confezione:
1 set
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Codice prodotto. Quantità Dimensione della confezione
15829081 1 Kit 1 set
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso
Codice prodotto. 15829081 Fornitore Gibco™ N. del fornitore A35684
 Articolo soggetto a restrizioni
Verfügbar ab: 24-12-2026
Aggiungi al carrello
Aggiungi al carrello

missing translation for 'validMainframeMsg'

Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso

The LV-MAX Lentiviral Production System is the first optimized system that provides a scalable and high-yield lentiviral vector production.

The Gibco LV-MAX Lentiviral Production System is an optimized, scalable system designed to maximize lentiviral vector production. This system is specifically designed for high-density suspension cultures of HEK293-derived Viral Production Cells, which are adapted to a chemically defined, serum-free, and protein-free LV-MAX Production Medium. The kit also includes a high-efficiency, cationic, lipid-based transfection reagent, LV supplement, and LV enhancer, designed for the transient transfection of high-density suspension-adapted Viral Production Cells. All components work synergistically to generate superior and functional lentiviral particles under serum-free conditions compared to conventional polyethylenimine (PEI).

Key features of the LV-MAX Lentiviral Production System

  • High LV yields—achieves functional titers up to 1 x 108 TU/mL (unconcentrated)
  • High-density growth—supports growth of Viral Production Cells at densities greater than 1 x 107 cells/mL for maximum vector output
  • AOF formulation—chemically defined, serum-free, and animal-origin-free medium ensures consistent performance by eliminating variability from undefined components
  • Ready-to-use—no media supplementation required; simplifies workflows and provides reliable, lot-to-lot reproducibility in lentivirus production
  • Expression system compatible—fully compatible with the LV-MAX Lentiviral Production System for seamless integration into end-to-end lentivirus manufacturing processes
  • Scalable and reproducible transfection and production—validated from 96–well plates to multi‐liter bioreactors, enabling easy scale-up without sacrificing cell yields
  • Easy and robust culture and transfection protocols, seamlessly integrating into any transient production workflow

Kit components

  • LV-MAX Viral Production Cells (VPC)—HEK293-derived cells adapted to high-density suspension culture, providing a robust platform for lentiviral vector production
  • LV-MAX Production Medium—a chemically defined, serum-free, protein-free medium, specially developed for high-density growth and transfection of Gibco Viral Production Cells
  • LV-MAX Transfection Reagent—a high-efficiency, cationic, lipid-based reagent uniquely formulated for co-transfecting multiple plasmids into high-density Viral Production Cell cultures. This reagent ensures high transfection efficiency with minimal toxicity.
  • LV-MAX Supplement—an optimized, chemically defined, serum-free, protein-free, animal origin-free formulation designed to suppress cell growth during transfection. It enhances lentiviral vector production without compromising cell viability or interfering with the production process.
  • LV-MAX Enhancer—a proprietary, animal origin-free formulation that significantly boosts lentiviral vector production

Applications

  • Gene therapy—ideal for the production of lentiviral vectors for gene therapy research and development
  • Cell therapy—supports the production of lentiviral vectors for cell therapy applications, enabling a seamless transition from discovery to clinical production
  • Research and development—provides a reliable and scalable solution for lentiviral vector production in various research settings

Components are available in RUO or CTS

Offered as both a Research Use Only (RUO) version and a GMP-compliant Cell Therapy Systems (CTS) version to support translational and clinical-scale applications.

TRUSTED_SUSTAINABILITY

Specifica

Linea cellulare Viral Production Cell-Line
Forma Liquid
Product Type Lentiviral Production System
Linea di prodotti LV-MAX
Quantità 1 Kit
Shipping Condition Approved for shipment at Room Temperature or on Wet or Dry Ice
Content And Storage • 1 L LV-MAX Production Medium. Store at 2–8°C, protect from light.
• 0.3 L LV-MAX Transfection Kit. Store at 2–8°C, protect from light.
• 2 vials of Viral Production Cells. Store in liquid nitrogen until ready to use. Do not store the cells at -80°C.

Tipo di erogazione Lentiviral, Transfection
Culture Type Suspension Cell Culture
Sistema di espressione Transient

For Research Use Only. Not for use in diagnostic procedures.

Titolo del prodotto
Selezionare un problema

Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.